Last Updated:
Name Designation Appointment Date Status
Ameerjan Abdulrahman

Appointed as Director since June 2012

 Director 05-Jun-2012 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Lamcy Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Ifteqar Ahmed Cheeda

Appointed as Director since June 2012

 Director 05-Jun-2012 Current
Jameel Ahmed Syed

Appointed as Director since June 2012

 Director 08-Jun-2012 Current
Anees Ahmed

Appointed as Director since June 2012

 Director 08-Jun-2012 Current

People Timeline

Explore the timeline of key personnel in Lamcy Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address No.65-A, 2Nd Block, 30Th Cross, Rajaji Nagar,, Bengaluru Karnataka, 560010, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 560010
  • Country India
  • Website -
Frequently Asked Questions
You can contact Lamcy Pharmaceuticals Private Limited through their registered address at No.65-A, 2Nd Block, 30Th Cross, Rajaji Nagar,, Bengaluru Karnataka, 560010, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Lamcy Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • AMEERJAN ABDULRAHMAN
  • IFTEQAR AHMED CHEEDA
  • JAMEEL AHMED SYED
  • ANEES AHMED
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available